TCM
CCCC icon

Tang Capital Management’s C4 Therapeutics CCCC Stock Holding History

Tang Capital Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-900,000
Closed -$2M – 97
2025
Q3 		$2M Hold
900,000
– – 0.08% 128
2025
Q2 		$1.29M Hold
900,000
– – 0.07% 143
2025
Q1 		$1.44M Hold
900,000
– – 0.08% 139
2024
Q4 		$3.24M Buy
900,000
+200,000
+29% +$994K 0.21% 90
2024
Q3 		$3.99M Buy
700,000
+500,000
+250% +$3.01M 0.29% 83
2024
Q2 		$924K Buy
+200,000
New +$1.19M 0.09% 96

Other funds holding CCCC

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return